Merck & Co. Finite-Lived Intangible Assets, Accumulated Amortization increased by 11.4% to $28.73B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.4%, from $25.79B to $28.73B. Over 5 years (FY 2020 to FY 2025), Finite-Lived Intangible Assets, Accumulated Amortization shows an upward trend with a 8.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising balance relative to gross assets indicates an aging portfolio of intangible assets nearing the end of their useful lives.
The cumulative amount of amortization expense recognized against finite-lived intangible assets since their acquisition...
Standard accounting metric; peers with older acquisition cycles will show higher accumulated amortization relative to gross assets.
other_finite_lived_intangible_assets_accumulated_amortization| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $19.51B | $21.48B | $23.59B | $25.79B | $28.73B |
| QoQ Change | — | +10.1% | +9.8% | +9.3% | +11.4% |
| YoY Change | — | +10.1% | +9.8% | +9.3% | +11.4% |